# A Clinical Pharmacodynamic and Pharmacogenetic Study of OPB-51602 in Patients With Advanced Solid Tumours

> **NCT01867073** · — · UNKNOWN · sponsor: **National University Hospital, Singapore** · enrollment: 20 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **OTHER:** Biomarker

## Key facts

- **NCT ID:** NCT01867073
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-05
- **Primary completion:** 2014-05
- **Final completion:** 2015-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2013-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01867073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01867073, "A Clinical Pharmacodynamic and Pharmacogenetic Study of OPB-51602 in Patients With Advanced Solid Tumours". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT01867073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*